The pentacyclic triterpene glycyrrhetinic acid is an interesting natural product exhibiting various biological activities. Especially its ability to induce apoptosis in tumor cells is of high scientific interest. In this study we altered the lipophilicity in ring A by derivatization at positions C-2 and C-3. The consequences of these variations on the cytotoxicity were investigated applying a colorimetric sulforhodamine B assay using 8 different human tumor cell lines. An acridine orange/ethidium bromide (AO/EB) test and a trypan blue test were used to determine the extent of apoptotic activity of some of these compounds.
Introduction
Glycyrrhetinic acid (1, Fig. 1 ) belongs to the group of triterpenoic acids; this group of natural products shows some interesting biological activities. Most prominent members are betulinic and oleanoic acid. Both compounds were shown to be cytotoxic towards tumor cell lines in in-vitro [1 -3] as well as in in vivo tests [4, 5] . Although 1 has a lower cytotoxicity than betulinic acid, 1 shows a similar apoptotic behavior [6 -9] . Another advantage of 1 is its occurrence in well accessible plants; 1 can be isolated in high yields from the roots of licorice [10, 11] . The parent structure of 1 displays three functionalities best suited for modifications: a carboxyl group in ring E at C-30, an α,β -unsaturated carbonyl function 0932-0776 / 11 / 0500-0521 $ 06.00 c 2011 Verlag der Zeitschrift für Naturforschung, Tübingen · http://znaturforsch.com located in ring C and a hydroxyl group in ring A at position C-3. In this study several functional modifications were performed at C-2 and/or C-3 in ring A. The principal aim was to alter the lipophilicity of the molecule by these modifications and to investigate them by a sulforhodamine B assay to determine their IC 50 values for 8 human tumor cell lines. To affirm an assumed apoptotic way of action, additional trypan blue and acridine orange/ethidium bromide (AO/EB) tests were performed.
Results and Discussion
The methyl and ethyl esters of 1 (2 and 3, Scheme 1) were synthesized by known procedures [9, 12] ; compounds 4 -6, being acetylated in position O-3, were synthesized in high yields by acetylating 1 or the esters 2 and 3 with acetyl chloride in the presence of pyridine.
Jones oxidation [13] of 1, 2 or 3 at C-2 (Scheme 2) gave ketones 7 -9. Compound 9 is characterized in its 13 C NMR spectrum by a signal at δ = 216.1 ppm (C=O). The reaction of 9 with periodic acid in DMSO [14] afforded the 3-keto-2-enol 11 as the main product; in its 1 H NMR spectrum 1-H is detected at δ = 7.16 ppm. In the corresponding 13 C NMR spectrum carbons C-1, C-2, and C-3 are found at δ = 130.9, 143.3 and 198.8 ppm, respectively. While the reaction of 9 with glacial acetic acid in the presence of p-tolu-enesulfonic acid gave 12, the reaction of 9 applying Wolff-Kishner conditions [15] afforded 10.
The reaction of 1, 2 or 3 (Scheme 3) with methanesulfonyl chloride in dry pyridine or triethylamine gave the corresponding mesylates 13 -15 in excellent yields.
An elimination reaction, however, occurred upon heating of 3 or of the mesylates 13 or 14 in dry DMF in the presence of a base, and products 16 -18 were obtained although the yields of these reactions never exceeded 50 %. Applying Mitsunobu conditions [16] , however, gave 18 in 90 % isolated yield. The 2,3-epoxide 19 was obtained from 18 by reaction with m-CPBA in dichloromethane. Reaction of 2 with 1,1 -thiocarbonyl-diimidazole [13] gave 20 whose reaction with AIBN gave 21 in 18 % yield.
Thus, these variations in ring A afforded compounds differing significantly in lipophilicity compared to parent 1. Although most of these compounds showed higher IC 50 values than 1 in the corresponding SRB assays, a few of them gave IC 50 values < 30 µ M. All acetates 4 -6 and oxidized compounds 7 -9 did not show any significant antitumor activity. With a few exceptions (e. g. 17 on A2780 cells), the mesylates 13 -15 and deoxygenated compounds 16 -18, showed a similar behavior. Deoxidized 10 and 21 gave comparable results in this assay; for A2780 ovarian cancer cells, however, 21 showed a significantly higher activity than 10. The derivatives 12 and 19 are almost inactive within the limits of our test (30 µ M) whereas the cytotoxicity of 11 is comparable to that of 3. Interestingly enough, 12 is cytotoxic especially against SW1736 human thyroid cancer cells (Table 1) .
Two of these derivatives (11 and 15) were selected as suitable candidates to investigate their ability to induce apoptosis in A549 lung carcinoma cells using an In this study we were able to synthesize a series of glycyrrhetinic acid derivatives differing in ring A. In summary, acetylated derivatives exhibited a lower cytotoxicity than the parent compound. This is in excellent agreement with previous findings for the corresponding betulinic or ursolic acid derivatives [17 -19] . A similar trend was observed for oxidized derivatives 7 -9 when compared to the corresponding analogs in the ursolic or oleanoic acid series [19] , but a different behavior was established [20, 21] for betulinic acid derivatives.
Usually esters of triterpenoic acids are more cytotoxic than the corresponding acids [9] but this seems to be not necessarily true for all derivatives of 1. Apoptotic behavior, however, is retained by-and-large in this series of compounds despite the changes in the substitution pattern in ring A.
Experimental Section

General methods
Reagents were bought from commercial suppliers and used without any further purification. NMR spectra were measured on Varian Gemini 200, Gemini 2000 or Unity 500 spectrometers at 27 • C with tetramethylsilane as an internal standard, δ values are given in ppm and J in Hz. Mass spectra were taken on a Finnigan MAT TSQ 7000 instrument (electron spray, voltage 4.5 kV, sheath gas nitrogen). IR spectra were recorded on a Perkin-Elmer FT-IR spectrometer Spectrum 1000, optical rotations on a Perkin-Elmer 341 polarimeter (1 cm micro cell, 20 • C), and UV/Vis spectra on a PerkinElmer unit, Lambda 14. Melting points were measured with a Leica hot stage microscope and are uncorrected. Elemental analysis was done on a Foss-Heraeus Vario EL unit. TLC was performed on silica gel (Merck 5554, detection by UV absorption). Solvents were dried before use according to usual procedures. Derivatives 2 and 3 were synthesized by known procedures [9, 12] .
Cell lines and culture conditions
The cell lines 518A2, 8505C, A2780, A549, DLD-1, Lipo, MCF-7 and SW1736 were included in this study. Cultures were maintained as monolayers in RPMI 1640 (PAA Laboratories, Pasching, Germany) supplemented with 10 % heat inactivated fetal bovine serum (Biochrom AG, Berlin, Germany) and penicillin / streptomycin (PAA Laboratories) at 37 • C in a humidified atmosphere of 5 % CO 2 / 95 % air.
Cytotoxicity assay [22] The cytotoxicity of the compounds was evaluated using the sulforhodamine-B (SRB) (Sigma Aldrich) microculture colorimetric assay. In short, exponentially growing cells were seeded into 96-well plates on day 0 at the appropriate cell densities to prevent confluence of the cells during the period of experiment. After 24 h, the cells were treated with serial dilutions of the compounds (0 -100 µ M) for 96 h. The final concentration of DMSO or DMF solvent never exceeded 0.5 %, which was non-toxic to the cells. The percentages of surviving cells relative to untreated controls were determined 96 h after the beginning of drug exposure. After a 96 h treatment, the supernatant medium from the 96 well plates was discarded, and the cells were fixed with 10 % TCA. For a thorough fixation, the plates were allowed to rest at 4 • C. After fixation, the cells were washed in a strip washer. The washing was done four times with water using alternate dispensing and aspiration procedures. The plates were then dyed with 100 µL of 0.4 % SRB (sulforhodamine B) for about 20 min. After dying the plates were washed with 1 % acetic acid to remove the excess of the dye and allowed to air-dry overnight. 100 µL of 10 mM Tris base solution was added to each well, and the absorbance was measured at 570 nm (using a 96 well plate reader, Tecan Spectra, Crailsheim, Germany). The IC 50 was estimated by linear regression between the value before and after the 50 % line is crossed in a dose-response curve.
Apoptosis test -acridine orange/ethidium bromide (AO/EB)
Apoptotic cell death was analyzed by acridine orange/ethidium bromide dye using fluorescence microscopy on A549 cells. Approx. 500 000 cells were seeded in cell culture flasks and were allowed to grow for 24 h. The medium was removed, and the loaded medium was added. After 24 -48 h, the supernatant medium was collected and centrifuged; the pellet was suspended in phosphate-buffer saline (PBS) and centrifuged again. The liquid was removed, and the pellet was suspended in PBS. After mixing the suspension with a solution of AO/EB, analysis was performed under a fluorescence microscope. While a green fluorescence shows apoptosis, a red colored nucleus indicates necrotic cells.
Apoptosis test -trypan blue cell counting
Approx. 500 000 cells (A549) were seeded in cell culture flasks and allowed to grow for 1 d. After removing the medium, the loaded medium was introduced, and the flasks were incubated for about 24 -48 h. The supernatant medium was collected and centrifuged, and the cell pellet was suspended in PBS and centrifuged again. Equal amounts of a Trypan blue solution (0.4 % in phosphate buffer saline, pH = 7.2) and a suspension of the pellet in PBS were mixed and put on chamber slides (invitrogen TM ). An automatic cell counter (invitrogen TM countess R automated cell counter) was used for counting the cells, differentiating between cells with and without an intact cell membrane.
(3β )-3-(Acetyloxy)-11-oxo-olean-12-en-30-oic acid (4)
Compound 1 (1.01 g, 2.2 mmol) was dissolved in dry dichloromethane (50 mL) containing dry pyridine (5 mL). Acetyl chloride (0.28 mL, 3.94 mmol) was added, and the mixture was stirred at r. t. for 40 h. Aqueous workup and extraction with CHCl 3 (3 × 30 mL) gave crude 4 whose recrystallization from methanol yielded 4 (1. 
Methyl (3β )-3-(acetyloxy)-11-oxo-olean-12-en-30-oate (5)
Compound 2 (360 mg, 0.75 mmol) was dissolved in a mixture of dry dichloromethane (30 mL) and dry pyridine (2 mL), and acetylchloride (1.1 ml, 1.5 mmol) was added. After 2 h of stirring at r. t., the mixture was washed with water (30 mL). The aqueous layer was extracted with CHCl 3 (3 × 20 mL), and the extracts were dried (Na 2 SO 4 ), filtered and evaporated to dryness. Recrystallization from methanol 
Ethyl (3β )-3-(acetyloxy)-11-oxo-olean-12-en-30-oate (6)
To a solution of 3 (215 mg, 0.43 mmol) in dry dichloromethane (50 mL) and dry pyridine (5 mL), acetyl chloride (0.8 mL, 1.1 mmol) was added and the mixture stirred for 2 h at r. t. Aqueous workup followed by extraction with CHCl 3 (3 × 20 mL), and recrystallization from methanol gave 6 (210 mg, 90 %) as colorless crystals. M. p. ν = 3442br, 2958s,  2874m, 1731s, 1654s, 1466w, 1390m, 1365m, 1316w, 1246s,  1215m, 1174m, 1152m, 1086w, 1027m, 1000w cm −1 . 
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3,11-Dioxo-olean-12-en-30-oic acid (7)
To a solution of 1 (600 mg, 1.3 mmol) in acetone (100 mL), CrO 3 (150 mg, 1.5 mmol) in sulfuric acid (1 M, 15 mL) was added. The mixture was stirred at r. t. for 1 h, followed by the addition of ethanol (50 mL). The precipitate was filtered off, and the filtrate was evaporated to dryness. Recrystallization from methanol afforded 7 ν = 3435br, 2965s, 1728s,  1683s, 1645s, 1457w, 1386m, 1367w, 1347w, 1328w, 1279w,  1250w, 1206m, 1144s, 1110w, 1087m, 1028w 13 
Methyl 3,11-dioxo-olean-12-en-30-oate (8)
A mixture of 7 (1.80 g, 3.84 mmol) and potassium carbonate (4.30 g, 31.1 mmol) in dry DMF (80 mL) was stirred at r. t. for 20 min. Iodomethane (3 mL, 48.2 mmol) was added, and stirring was continued for an additional 24 h. The solvent was removed under reduced pressure and the residue suspended in water (40 mL). The suspension was extracted with dichloromethane (3 × 30 mL), and the combined extracts were washed with brine (20 mL), dried (Na 2 SO 4 ), filtered and evaporated. Recrystallization from methanol gave 8 ( ν = 3428br, 2962s, 2874s, 1725s, 1706s,  1655s, 1616m, 1540w, 1457m, 1427m, 1386m, 1366m,  1318m, 1280m, 1245m, 1220s, 1181s, 1153s, 1110m , 7 -H), 1.43 (m, 1 H, 1 -H), 1.39 (m,  1 H, 22-H), 1.37 (s, 3 H, 27-H), 1.32 (m, 2 H, 21 -H and  22 -H), 1.28 (m, 1 H, 5-H), 1.27 (s, 3 H, 25-H), 1.21 (m,  1 H, 16 -H), 1.17 (s, 3 H, 26-H), 1.15 (s, 3 H, 29-H), 1.11  (s, 3 H, 23-H), 1.07 (s, 3 H, 24-H), 1.03 (m, 1 H, 15 -H) , 0.82 (s, 3 H, 28-H). - 13 (6) 
Ethyl 3,11-dioxo-olean-12-en-30-oate (9)
Compound 3 (1.03 g, 2.1 mmol) was dissolved in acetone (180 mL), followed by the addition of CrO 3 (227 mg, 2.3 mmol) in diluted sulfuric acid (15 mL). The solution was stirred at r. t. for 70 min. Ethanol (50 mL) was added, and the precipitate was filtered off. The filtrate was evaporated to dryness, and recrystallization from methanol gave 9 
11-Oxo-olean-12-en-30-oic acid (10)
To a mixture of 9 (797 mg, 1.6 mmol) and potassium hydroxide (778 mg, 13.9 mmol) in dry diethylene glycol (20 mL), hydrazine hydrate (80 %, 1.2 mL, 18.4 mmol) was added dropwise. After 24 h of stirring at 200 • C the mixture was cooled, water (50 mL) was added, and the mixture was extracted with dichloromethane (3 × 20 mL). The combined organic layers were dried (Na 2 SO 4 ), filtered and evaporated to dryness. Purification by chromatography (silica gel, dichloromethane / methanol / ammonia 90 : 10 : 
Ethyl 2-hydroxy-3,11-dioxo-olean-1,12-dien-30-oate (11)
To a solution of 9 (1.07 g, 2.10 mmol) in dry DMSO (25 mL), periodic acid (580 mg, 3.3 mmol) was added. The mixture was stirred at 50 • C for 3 d and then poured into water (30 mL). The aqueous layer was extracted with dichloromethane (3 × 20 mL), and the combined extracts were dried (Na 2 SO 4 ), filtered and evaporated. Purification by chromatography (silica gel, chloroform / ether 9 : 1) gave 11 ν = 3438br,  2977s, 2361w, 1726s, 1660s, 1465m, 1387m, 1314w, 1282w,  1217m, 1153m, 1087w, 1058m, 1030w, 879m, 756s 
Ethyl (3β )-3-(acetyloxy)-11-oxo-olean-2,12-dien-30-oate (12)
Compound 9 (990 mg, 1.99 mmol) was dissolved in glacial acetic acid (15 mL) and heated to 80 • C. p-TsOH (40 mg, 0.23 mmol) was added, and stirring was continued for an additional 24 h. The mixture was cooled and diluted with dichloromethane (30 mL). After washing with water (20 mL), the aqueous layer was extracted with dichloromethane (3 × 30 mL), and the extracts were dried (Na 2 SO 4 ), filtered and evaporated to dryness. Chromatographic purification (silica gel, chloroform / ether 9 : 2874s, 2840m, 1751s, 1725s, 1657s, 1623m, 1457m, 1388s,  1364s, 1325m, 1281m, 1259s, 1217s, 1160s, 1101m, 1083s 53 (m, 1 H, 6-H), 1.47 (m, 1 H, 6 -H), 1.44 (m, 1 H, 7 -H),  1.37 (m, 1 H, 22-H), 1.35 (s, 3 H, 27-H 21 (m, 1 H, 16 -H), 1.15 (s, 3 H, 26-H), 1.13 (s, 3 H, 29-H),  1.03 (s, 3 H, 23-H), 1.01 (m, 1 H, 15 -H), 0.95 (s, 3 H, 23-H 
(3β )-3[(Methylsulfonyl)oxy]-11-oxo-olean-12-en-30-oic acid (13)
Compound 1 (527 mg, 1.2 mmol) was dissolved in dry pyridine (15 mL), methanesulfonyl chloride (120 µL, 1.6 mmol) was added, and the mixture was stirred at r. t. (14) Following the procedure given for the preparation of 13, from 2 (522 mg, 1.1 mmol), dry pyridine (15 mL) and methanesulfonyl chloride (126 µL, 
Ethyl (3β )-3[(methylsulfonyl)oxy]-11-oxo-olean-12-en-30-oate (15)
Following the procedure given for the preparation of 13, from 3 (1.41 g, 2.8 mmol), triethylamine (1.5 mL, 10.8 mmol) and methanesulfonyl chloride (340 µL, 4.4 mmol) 15 (1.50 g, 94 %) was obtained as a colorless powder. M. p. 172 -175 • C; R f = 0.51 (hexane / ethyl ac-
